ArticleProtein & cell2026

Tumor cell intrinsic dsRNA innate immune response triggered by PARP inhibitor is compromised in BRCA1-deficient breast cancer by repressing IRF3.

Cuiting Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.